Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 May;41(5):778–781. doi: 10.1038/bjc.1980.141

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.

H Pehamberger, H Ludwig, P Pötzi, W Knapp
PMCID: PMC2010310  PMID: 7426302

Abstract

Monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) was tested in 23 patients with histologically proven Hodgkin's disease and 29 healthy normal controls. Seven patients presented with active and 16 with inactive disease. The lytic capacity of the individual monocytes was significantly (P < 0.02) higher in patients with Hodgkin's disease than in normals. However, no significant difference was found between the numbers of monocytes in both groups of individuals, as determined by non-specific esterase staining. No correlation was found between the lytic capacity of monocytes and the activity of the disease.

Full text

PDF
778

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Björkholm M., Holm G., Mellstedt H., Pettersson D. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture. Clin Exp Immunol. 1975 Dec;22(3):373–377. [PMC free article] [PubMed] [Google Scholar]
  2. Case D. C., Hansen J. A., Corrales E., Young C. W., Dupont B., Pinsky C. M., Good R. A. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease. Cancer. 1976 Oct;38(4):1807–1815. doi: 10.1002/1097-0142(197610)38:4<1807::aid-cncr2820380458>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  3. Cohnen G., Augener W., Brittinger G., Douglas S. D. Rosette-forming lymphocytes in Hodgkin's disease. N Engl J Med. 1973 Oct 18;289(16):863–863. doi: 10.1056/NEJM197310182891616. [DOI] [PubMed] [Google Scholar]
  4. Currie G. A., Hedley D. W. Monocytes and macrophages in malignant melanoma. I. Peripheral blood macrophage precursors. Br J Cancer. 1977 Jul;36(1):1–6. doi: 10.1038/bjc.1977.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DIZON Q. S., SOUTHAM C. M. ABNORMAL CELLULAR RESPONSE TO SKIN ABRASION IN CANCER PATIENTS. Cancer. 1963 Oct;16:1288–1292. doi: 10.1002/1097-0142(196310)16:10<1288::aid-cncr2820161009>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  6. Eltringham J. R., Kaplan H. S. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:107–115. [PubMed] [Google Scholar]
  7. Hillinger S. M., Herzig G. P. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes. J Clin Invest. 1978 Jun;61(6):1620–1627. doi: 10.1172/JCI109082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kadin M. E., Stites D. P., Levy R., Warnke R. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease. N Engl J Med. 1978 Nov 30;299(22):1208–1214. doi: 10.1056/NEJM197811302992203. [DOI] [PubMed] [Google Scholar]
  9. Kjeldsberg C. R., Pay G. D. A qualitative and quantitative study of monocytes in patients with malignant solid tumors. Cancer. 1978 Jun;41(6):2236–2241. doi: 10.1002/1097-0142(197806)41:6<2236::aid-cncr2820410624>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  10. Leb L., Merritt J. A. Decreased monocyte function in patients with Hodgkin's disease. Cancer. 1978 May;41(5):1794–1803. doi: 10.1002/1097-0142(197805)41:5<1794::aid-cncr2820410522>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  11. Normann S. J., Schardt M., Sorkin E. Cancer progression and monocyte inflammatory dysfunction: relationship to tumour excision and metastasis. Int J Cancer. 1979 Jan 15;23(1):110–113. doi: 10.1002/ijc.2910230119. [DOI] [PubMed] [Google Scholar]
  12. Nyholm R. E., Currie G. A. Monocytes and macrophages in malignant melanoma. II. Lysis of antibody-coated human erythrocytes as an assay of monocyte function. Br J Cancer. 1978 Mar;37(3):337–344. doi: 10.1038/bjc.1978.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Poplack D. G., Bonnard G. D., Holiman B. J., Blaese R. M. Monocyte-mediated antibody-dependent cellular cytotoxicity: a clinical test of monocyte function. Blood. 1976 Dec;48(6):809–816. [PubMed] [Google Scholar]
  14. Snyderman R., Seigler H. F., Meadows L. Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst. 1977 Jan;58(1):37–41. doi: 10.1093/jnci/58.1.37. [DOI] [PubMed] [Google Scholar]
  15. Twomey J. J., Laughter A. H., Farrow S., Douglass C. C. Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest. 1975 Aug;56(2):467–475. doi: 10.1172/JCI108113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Urbanitz D., Fechner I., Gross R. Reduced monocyte phagocytosis in patients with advanced Hodgkin's disease and lymphosarcoma. Klin Wochenschr. 1975 May 1;53(9):437–440. doi: 10.1007/BF01493369. [DOI] [PubMed] [Google Scholar]
  17. Young R. C., Corder M. P., Haynes H. A., DeVita V. T. Delayed hypersensitivity in Hodgkin's disease. A study of 103 untreated patients. Am J Med. 1972 Jan;52(1):63–72. doi: 10.1016/0002-9343(72)90008-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES